Lizhe Wang

Prof. Lizhe Wang

The first hospital of Jilin University

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2019 in Biomedical Microdevices
Verified
Journal Article
Closed access
PDF file
RQRenna Qiu
Renna Qiu
FQFeng Qian
Feng Qian
XWXiaofeng Wang
Xiaofeng Wang
HLHongjun Li
Hongjun Li
LWLizhe Wang
Lizhe Wang

7 January 2019 in Sensors
Verified
Journal Article
Open access
PDF file
XWXinqi Wang
Xinqi Wang
KMKeming Mao
Keming Mao
LWLizhe Wang
Lizhe Wang
PYPeiyi Yang
Peiyi Yang
DLDuo Lu
Duo Lu
PHPing He
Ping He
Lung cancer is one of the most deadly diseases around the world representing about 26% of all cancers in 2017. The five-year cure rate is only 18% despite great progress in recent diagnosis and treatment. Before diagnosis, lung nodule classification is a key step, especially since automatic classification can help clinicians by providing a valuable opinion. Modern computer vision and machine learning technologies allow very fast and reliable CT image classification. This research area has become very hot for its high efficiency and labor saving. The paper aims to draw a systematic review of the state of the art of automatic classification of lung nodules. This research paper covers published works selected from the Web of Science, IEEEXplore, and DBLP databases up to June 2018. Each paper is critically reviewed based on objective, methodology, research dataset, and performance evaluation. Mainstream algorithms are conveyed and generic structures are summarized. Our work reveals that lung nodule classification based on deep learning becomes dominant for its excellent performance. It is concluded that the consistency of the research objective and integration of data deserves more attention. Moreover, collaborative works among developers, clinicians, and other parties should be strengthened.

1 January 2020 in Drug Delivery
Verified
Journal Article
Open access
RQRenna Qiu
Renna Qiu
DSDenghua Sun
Denghua Sun
YBYuzhuo Bai
Yuzhuo Bai
JLJiannan Li
Jiannan Li
LWLizhe Wang
Lizhe Wang
Osteosarcoma is the most common primary malignant bone tumor in childhood and adolescence. Currently, surgery combined with chemotherapy is the main treatment for osteosarcoma. However, the long-term survival of patients with metastatic osteosarcoma is unsatisfactory. Therefore, new treatment methods to improve the prognosis of patients with osteosarcoma are required. The present study aimed to develop nanocarriers with both tumor targeting and reduction responsiveness abilities, and to improve the therapeutic effect and reduce toxicity by loading traditional small molecule antitumor drugs. The tumor targeting peptide-decorated, doxorubicin (DOX)-loaded mPEG-P(Phe-co-Cys) nanoparticles were developed successfully through the ring-opening polymerization of amino acids. The peptide VATANST (STP) can specifically bind with vimentin, which is highly expressed on the osteosarcoma cell surface, resulting in tumor targeting effects. The nanoparticle is core–shell structured to protect the loaded DOX during blood flow. The disulfide bonds within the nanoparticles are sensitive to the osteosarcoma microenvironment, which has high glutathione (GSH) levels. Under the enhanced permeability and retention and active tumor targeting effects, the STP-decorated DOX-loaded nanoparticles accumulated in tumor tissues. High GSH levels can rupture disulfide bonds, resulting in the controlled release of DOX, which will cause necrosis of tumor cells. The characteristics of the synthesized nanoparticles, DOX release profiles in vitro and in vivo, cytotoxicity analysis, animal study, and safety evaluation were performed. The nanoparticles could increase the tumor inhibition efficiency against osteosarcoma and reduce the side effects of DOX to major organs. The STP-decorated mPEG-P(Phe-co-Cys) nanoparticles might be a suitable drug delivery system for DOX to treat osteosarcoma.

14 August 2019 in Biomedical Microdevices
Verified
Journal Article
Closed access
PDF file
RQRenna Qiu
Renna Qiu
JLJian Li
Jian Li
DSDenghua Sun
Denghua Sun
HLHongjun Li
Hongjun Li
FQFeng Qian
Feng Qian
LWLizhe Wang
Lizhe Wang